Advancements in Cataract & Glaucoma Treatments
Date: 29/10/2024 (AEST)
Venue: 18 Scott Street, Toowoomba, QLD, 4350
Provider: Toowoomba Surgicentre
Contact: Kate Staib, [E] kate.staib@tmbasurgi.com.au, [P] 0746593100
Activity Outline
An informational evening hosted by the Toowoomba Surgicentre, sponsored by Glaukos, and in partnership with local Opthalmic Surgeons Dr Ashley Seawright, Dr Michael Statham & Dr Keith Zabell. Topics covered include IOL choices, Advancements in Phaco Technology, Advancements in Diagnostic Technology, and a dry lab covering the new istent (iS3) and preserflo technology. Food and beverage will be provided on the night.Learning Objectives
- Know the different IOL choices available on the market currently, the local preferences, and the differences between the lens types and reasons behind the patient choices.
- Understand more about the diagnostic technology used by Opthalmologists prior to surgical intervention
- Understand the basics of phacoemulsification used throughout the diagnostic and surgical procedure
- Be aware of the new technology released from Glaukos, as well as have a basic understanding of the implantation process.
Max CPD hours awarded: 2
Session Information
| Name |
|---|
| IOL Choices |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Advancements in Diagnostic Technology |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Phaco Advancements |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Advancements in Glaucoma Treatment |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |